GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnaptysBio Inc (NAS:ANAB) » Definitions » E10

ANAB (AnaptysBio) E10 : $-2.96 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is AnaptysBio E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AnaptysBio's adjusted earnings per share data for the three months ended in Sep. 2024 was $-1.140. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.96 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-01-18), AnaptysBio's current stock price is $15.85. AnaptysBio's E10 for the quarter that ended in Sep. 2024 was $-2.96. AnaptysBio's Shiller PE Ratio of today is .


AnaptysBio E10 Historical Data

The historical data trend for AnaptysBio's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnaptysBio E10 Chart

AnaptysBio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -2.57

AnaptysBio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.57 -2.72 -2.84 -2.96

Competitive Comparison of AnaptysBio's E10

For the Biotechnology subindustry, AnaptysBio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AnaptysBio's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnaptysBio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AnaptysBio's Shiller PE Ratio falls into.



AnaptysBio E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AnaptysBio's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-1.14/133.0289*133.0289
=-1.140

Current CPI (Sep. 2024) = 133.0289.

AnaptysBio Quarterly Data

per share eps CPI Adj_EPS
201412 -0.004 99.070 -0.005
201503 -0.004 99.621 -0.005
201506 -0.001 100.684 -0.001
201509 -0.103 100.392 -0.136
201512 -0.248 99.792 -0.331
201603 -0.063 100.470 -0.083
201606 0.012 101.688 0.016
201609 -0.079 101.861 -0.103
201612 -0.235 101.863 -0.307
201703 -0.750 102.862 -0.970
201706 -0.130 103.349 -0.167
201709 -0.450 104.136 -0.575
201712 -0.300 104.011 -0.384
201803 -0.630 105.290 -0.796
201806 -0.570 106.317 -0.713
201809 -0.660 106.507 -0.824
201812 -0.640 105.998 -0.803
201903 -0.820 107.251 -1.017
201906 -0.890 108.070 -1.096
201909 -1.150 108.329 -1.412
201912 -0.750 108.420 -0.920
202003 -0.300 108.902 -0.366
202006 -0.790 108.767 -0.966
202009 -0.870 109.815 -1.054
202012 1.230 109.897 1.489
202103 -0.660 111.754 -0.786
202106 -0.020 114.631 -0.023
202109 -0.240 115.734 -0.276
202112 -1.180 117.630 -1.334
202203 -1.310 121.301 -1.437
202206 -1.150 125.017 -1.224
202209 -1.180 125.227 -1.254
202212 -0.930 125.222 -0.988
202303 -1.580 127.348 -1.650
202306 -1.500 128.729 -1.550
202309 -1.410 129.860 -1.444
202312 -1.590 129.419 -1.634
202403 -1.640 131.776 -1.656
202406 -1.710 132.554 -1.716
202409 -1.140 133.029 -1.140

Add all the adjusted EPS together and divide 10 will get our e10.


AnaptysBio  (NAS:ANAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


AnaptysBio E10 Related Terms

Thank you for viewing the detailed overview of AnaptysBio's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


AnaptysBio Business Description

Traded in Other Exchanges
Address
10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Executives
Hollings Renton director
Paul F. Lizzul officer: Chief Medical Officer 30699 RUSSELL RANCH ROAD, SUITE 140, WESTLAKE VILLAGE CA 91362
Eric J Loumeau officer: General Counsel C/O HOLLIS-EDEN PHARMACEUTICALS, 4435 EASTGATE MALL STE.400, SAN DIEGO CA 92121
Dennis Mulroy officer: Chief Financial Officer
Ecor1 Capital, Llc 10 percent owner 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Dennis M Fenton director
Daniel Faga director 3737 MARKET STREET, SUITE 1300, PHILADELPHIA PA 19104
John A Orwin director C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063
Rita Jain director C/O AKEBIA THERAPEUTICS, INC., 245 FIRST STREET, SUITE 1100, CAMBRIDGE MA 02142
Hamza Suria director, officer: President, CEO C/O ANAPTYSBIO, INC., 10421 PACIFIC CENTER COURT, SUITE 200, SAN DIEGO CA 92121
Oleg Nodelman director, 10 percent owner 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Magda Marquet director ALTHEADX INC., 3550 DUNHILL STREET, SAN DIEGO CA 92121
J. Anthony Ware director C/O ANAPTYSBIO, INC., 10421 PACIFIC CENTER COURT, SUITE 200, SAN DIEGO CA 92121
Laura Hamill director 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Marco Londei officer: Chief Medical Officer C/O ANAPTYSBIO, INC., 10421 PACIFIC CENTER COURT, SUITE 200, SAN DIEGO CA 92121